
Please try another search
Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.
Name | Age | Since | Title |
---|---|---|---|
Markus Gernot Schmieta | - | 2019 | Chairman of the Supervisory Board |
Hartmut Brandt | - | 2019 | Deputy Chairman of the Supervisory Board |
Walter Leven | - | 2024 | Member of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review